行情

AMRS

AMRS

阿米瑞斯公司
NASDAQ

实时行情|Nasdaq Last Sale

3.710
-0.050
-1.33%
已收盘, 16:00 11/19 EST
开盘
3.720
昨收
3.760
最高
3.910
最低
3.675
成交量
58.70万
成交额
--
52周最高
6.06
52周最低
1.870
市值
3.84亿
市盈率(TTM)
-1.3252
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AMRS 新闻

  • American Diabetes Association Announces Amyris CEO John Melo as Executive Committee Chair of 2020 Wine Country Tour de Cure
  • PR Newswire.21小时前
  • Amyris Advances to Regulatory Stage with Another Significant Health & Nutrition Molecule
  • PR Newswire.1天前
  • Amyris Closes on Exchange to Resolve CVI Heights Debt
  • PR Newswire.4天前
  • Amyris - Another Disappointing Quarter And More Toxic Debt
  • Seeking Alpha - Article.6天前

更多

所属板块

通用化学品
-0.66%
化学品
-0.63%

热门股票

名称
价格
涨跌幅

AMRS 简况

Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. The Company is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including performance chemicals, solvents, lubricants, flavors and fragrances (F&F), cosmetics ingredients, pharmaceuticals, and nutraceuticals. The Company intends to apply its technology to the development of pharmaceutical products. The Company applies its bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products.
展开

Webull提供Amyris Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。